Latest Sanofi Stories
Market Access Challenges for Sanofi/Genzyme's Aubagio Highlight the Hurdles New Multiple Sclerosis Agents Face in Europe, According to Findings from Decision Resources Group BURLINGTON, Mass.,
Nasal allergy sufferers now have the most effective player on their team to relieve even the toughest nasal allergy symptoms CHATTANOOGA, Tenn., April 15, 2014 /PRNewswire/ -- Nancy
Editor Note: For more information about this release, please scroll to bottom. LONDON, April 8, 2014 /PRNewswire/ -- The trading session on Monday, April 07, 2014
- Data Advances microRNA Oncology Portfolio - LA JOLLA, Calif., April 7, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.
LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
DUBLIN, April 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/37ktl3/global_and ) has announced the addition of the "Global and
BRANFORD, Conn., April 2, 2014 /PRNewswire/ -- New Haven Pharmaceuticals, Inc.
New Site Offers Fast and Modern Interface Designed to Simplify Shopping Experience for IT Professionals and Provide Dynamic Real-time Quotes on Equipment ATLANTA,
DUBLIN and LAVAL, Quebec, March 25, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S.
- A gift; a largess; a gratuity; a present; a dole.